Drugs / DRM02
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01993420 | Oct 2013 → Feb 2014 | atopic eczema | Dermira, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01993446 | Oct 2013 → Feb 2014 | rosacea | Dermira, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01993433 | Oct 2013 → Feb 2014 | psoriasis | Dermira, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DRM02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01993446 ↗ |
| Route | Topical | “DRM02 Topical Gel, 0.25%” NCT01993420 ↗ |